(Q46610327)

23 December 2017

title

Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study (English)

1 reference

23 December 2017

0 references

1

Karina Danilowicz

1 reference

23 December 2017

Marcos Manavela

3

object named as

Marcos Manavela

1 reference

23 December 2017

Oscar Domingo Bruno

2

object named as

Oscar Domingo Bruno

1 reference

23 December 2017

author name string

Reynaldo Manuel Gomez

4

1 reference

23 December 2017

Ariel Barkan

5

1 reference

23 December 2017

publication date

1 January 2008

1 reference

23 December 2017

number of pages

7

1 reference

inferred from page(s)

published in

Pituitary

1 reference

23 December 2017

volume

11

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

279-285

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1007/s11102-008-0126-2

exact match

0 references

cites work

Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11102-008-0126-2

Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis

21 January 2018

1 reference

12 December 2020

Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects.

1 reference

12 December 2020

Loss of body cell mass in Cushing's syndrome: effect of treatment.

1 reference

12 December 2020

Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial

1 reference

12 December 2020

Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism

1 reference

12 December 2020

Premature mortality due to cardiovascular disease in hypopituitarism

1 reference

12 December 2020

Supraphysiological growth hormone: less fat, more extracellular fluid but uncertain effects on muscles in healthy, active young adults

1 reference

12 December 2020

Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing's syndrome

1 reference

12 December 2020

Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome.

1 reference

12 December 2020

Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial

1 reference

12 December 2020

A densitometric and morphometric analysis of the skeleton in adults with varying degrees of growth hormone deficiency

1 reference

12 December 2020

Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults

1 reference

12 December 2020

Endocrine and metabolic diseases. Adrenal diseases

1 reference

12 December 2020

Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency.

1 reference

12 December 2020

The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency

1 reference

12 December 2020

Effective reversibility of the signs and symptoms of hypercortisolism by bilateral adrenalectomy

1 reference

12 December 2020

Glucocorticoid replacement therapy: are patients over treated and does it matter?

1 reference

12 December 2020

Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status--3-year results from the HypoCCS Database

1 reference

12 December 2020

Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial.

1 reference

12 December 2020

The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients.

1 reference

12 December 2020

Long-term follow-up of the West of Scotland Coronary Prevention Study

1 reference

12 December 2020

The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.

1 reference

12 December 2020

Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?

1 reference

12 December 2020

Corticosteroid replacement therapy: twice or thrice daily?

1 reference

12 December 2020

Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency

1 reference

12 December 2020

Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy.

1 reference

12 December 2020

Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis

1 reference

12 December 2020

10.1007/S11102-008-0126-2

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017